TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03016884 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02952339 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03263208 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04567875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02296385 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT02514837 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04174287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04143139 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04839159 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04839159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04839159 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04839159 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00409617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02797847 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02532296 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT00271089 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01708174 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00921180 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02437955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00729183 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00663104 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02628795 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT01064492 — Predictive Biomarker (PRD): DGAT1 mRNA
Genes: DGAT1; AGRP1; DGAT
Study NCT00600938 — Predictive Biomarker (PRD): Liver iron
Study NCT02741908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01048021 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00959842 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03645655 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT03645655 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02893072 — Predictive Biomarker (PRD): MNT mRNA
Genes: MNT; BHLHD3; ROX
Study NCT00533533 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00702403 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00702403 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02381808 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02381808 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02381808 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02381808 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01329640 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02695745 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT01157507 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04375488 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02564614 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT04369794 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03921931 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00433056 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02476968 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02476968 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02463656 — Predictive Biomarker (PRD): PORCN mRNA
Genes: PORCN; MG61; PORC; PPN
Study NCT02952014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01523548 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00897065 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02181062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04650477 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study NCT03774277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02482103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04113278 — Predictive Biomarker (PRD): FLG2 mRNA
Genes: FLG2; IFPS
Study NCT00885560 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT00885560 — Predictive Biomarker (PRD): DRD1 mRNA
Genes: DRD1
Study NCT00885560 — Predictive Biomarker (PRD): MAOA mRNA
Genes: MAOA
Study NCT01048047 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00643097 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02641769 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02436421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00717015 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00717015 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02891668 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03823443 — Predictive Biomarker (PRD): MMP13 mRNA
Genes: MMP13
Study NCT01883219 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01883219 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00054418 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01574417 — Predictive Biomarker (PRD): NPC1L1 mRNA
Genes: NPC1L1
Study NCT01574417 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01235338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004695 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01783470 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01797289 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04130230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04130230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04130230 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT00188019 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT02305550 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT00298207 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02668952 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT02668952 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT00069212 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00074542 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03358004 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03358004 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03358004 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03702140 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05263687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04803019 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT03597503 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT03836196 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01461824 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03940456 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00520299 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT02724111 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT03880006 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00116441 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01279967 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT01754441 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04452422 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04076618 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01652170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03802240 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03802240 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03802240 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03010111 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00897988 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00897988 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04594356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04594356 — Safety Biomarker (SAF): Interleukin 1
Study NCT04594356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00860782 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00251017 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study NCT05475444 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00479934 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03147573 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02619006 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT02125864 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02125864 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03389269 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03389269 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03389269 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03736551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03757260 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02885389 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT02885389 — Predictive Biomarker (PRD): STXBP1 mRNA
Genes: STXBP1; UNC18A
Study NCT02885389 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT02885389 — Predictive Biomarker (PRD): GRIN2A mRNA
Genes: GRIN2A; NMDAR2A
Study NCT02885389 — Predictive Biomarker (PRD): MAGI2 mRNA
Genes: MAGI2; ACVRINP1; AIP1; KIAA0705
Study NCT04419662 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04419662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02045680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00264355 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00005326 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00256698 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01620593 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04614467 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT04614467 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04735978 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00537771 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02955368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04128163 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02866929 — Safety Biomarker (SAF): Interleukin 1
Study NCT02397967 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04319770 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04319770 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04599972 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00552344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02253628 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00245349 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01975376 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01975376 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00899366 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study NCT00003761 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT04509401 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study NCT01009736 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01009736 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03215329 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00071565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03322215 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03322215 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03322215 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03322215 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00896558 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03217786 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT01139736 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT02024399 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03089203 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04457609 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04457609 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04457609 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04457609 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT04457609 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study NCT04457609 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04457609 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04457609 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04457609 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00462202 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00316979 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT00239707 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02629692 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02629692 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04076800 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04076800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03121092 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03121092 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01948817 — Predictive Biomarker (PRD): Liver iron
Study NCT00573755 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01144091 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01442415 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03127657 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02228915 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04014075 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03506750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03506750 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT02801942 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT02801942 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study NCT02801942 — Predictive Biomarker (PRD): Proliferation marker protein Ki-67
Genes: MKI67
Study NCT02717988 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT01340404 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT04330261 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02139267 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02418728 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT03914651 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00704392 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00704392 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00704392 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT00704392 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01597440 — Predictive Biomarker (PRD): Mitochondrial n-acetylglutamate synthase
Genes: NAGS
Study NCT03126240 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03512119 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02849184 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03809156 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01155791 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01553721 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01553721 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02708472 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04308928 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02623699 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02371018 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01954810 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00001827 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00001827 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02029560 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01292317 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01292317 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01292317 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02451189 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02282891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00120510 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01122888 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00748514 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01316380 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00003838 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02164604 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02164604 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03749213 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00394693 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00063388 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00625040 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01353183 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03190967 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03190967 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02527902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02940197 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT00244777 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00565006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04099836 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04099836 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03480646 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT01444547 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT01644981 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03383055 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study NCT00483418 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01159821 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00524667 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00524667 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT03845335 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02443155 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00132522 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03565991 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03565991 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01461798 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01638169 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04066010 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03237429 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01255150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01255150 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF